Several innovative treatments are transforming diabetes management, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide standing out leading candidates. Retatrutide, a double GIP and GLP-1 target stimulant, demonstrates significant body mass decrease coupled with enhanced blood sugar le